“… ? | Dev: 8715, Ext val: 2147 | Dev models | Kanda et al, 2019 56 | Japan 2005–2017 | CTx: 52 | MIE/open | Dev: 355 | NA |
Wang et al, 2022 32 | China 2019–2021 | ICTx: 100 | MIE/open, TT | Dev: 78 | NA |
Reinersman et al, 2016 34 | USA 2009–2012 | CRTx: 80 | Total/hybrid MIE, TH/TT | Val: 136 | Ferguson |
Dev development, Val validation, Int internal, Ext external, NA not applicable, CTx chemotherapy, CRTx chemoradiotherapy, ICTx immunochemotherapy, MIE minimal invasive esophagectomy, OE open esophagectomy, TT transthoracal, TH transhiatal, TA thoracoabdominal, RAI risk analysis index, Rev revised, RAI-A administrative risk analysis index, mFI-5 5-factor modified frailty index, STS GTSD Society of Thoracic Surgeons General Thoracic Surgeons Database, aCCI age adjusted Charlson comorbidity index, CCI Charlson Comorbidity Index, ASA American Society of Anesthesiologists, O-POSSUM physiological and operative severity score for the enumeration of mortality and morbidity adjusted for oesophagogastric surgery, ACS NSQIP American College of Surgeons National Surgical Quality Improvement Program, ? unknown …”